RSS

Author Archives: mmfsolutionsg

Market Research of Keppel DC REIT

Image result for Keppel DC REIT

Keppel DC REIT (KDCREIT) reported its 3Q17 results which met our expectations. Gross revenue and NPI jumped 56.6% and 42.1% YoY to S$35.5m and S$32.3m, respectively.

This was largely driven by the acquisitions of the 90% interest of KDC SGP 3, Milan DC, Cardiff DC and to a smaller extent B10 DC in Dublin (half a month of contribution), coupled with higher variable income from KDC SGP 1 due to an increase in recurring revenue.

DPU grew 16.8% YoY to 1.74 S cents. If we make adjustments to account for the impact of the preferential offering exercise and a one-off net property tax refund in 3Q16, KDCREIT’s adjusted DPU would have increased 4.2% YoY.

For 9M17, KDCREIT’s gross revenue spiked up 41.4% to S$102.2m and formed 76.8% of our FY17 forecast. DPU rose 11.2% to 5.37 S cents (adjusted DPU +4.2% to 5.22 S cents) and constituted 74.0% of our full-year projection.

Operationally, KDCREIT’s portfolio occupancy creeped up 0.3 ppt QoQ to 93.4% as there was slight improvement recorded at KDC SGP 1 and Keppel DC Dublin 1.

Pertaining to Singapore’s data centre industry, management highlighted that while there are still some vacancies in the market, it remains upbeat that this space will eventually be absorbed in the foreseeable future given limited upcoming supply and robust demand, especially from the cloud service providers.

Maintain BUY and S$1.39 fair value estimate on KDCREIT.

More Update:Share trading tipsSGX Stock PicksShare Market signals for Singapore stock Market

Venture Corp Share Investment Singapore www.mmfsolutions.sg

Advertisements
 
Leave a comment

Posted by on October 17, 2017 in Stocks

 

Tags: , , , , , , , , , , , , ,

Equity Tips for Successful Share Investment

Paul Larson is a portfolio manager at OppenheimerFunds. Prior to this position, he was the chief equity strategist at Morningstar. During that period, he penned down some thoughts on what it would take to be a successful equity investor. We build on those. Think like an owner. Stocks represent ownership stakes in businesses and are not just pieces of paper to enable trading. Think like a business owner. If stocks are ownership slices of a business, we should value stocks like we value businesses. A business is worth the discounted value of all future cash flow that it can generate. Joe Mansueto,

Think like an owner. Stocks represent ownership stakes in businesses and are not just pieces of paper to enable trading. Think like a business owner. If stocks are ownership slices of a business, we should value stocks like we value businesses. A business is worth the discounted value of all future cash flow that it can generate. Joe Mansueto,

Stocks represent ownership stakes in businesses and are not just pieces of paper to enable trading. Think like a business owner. If stocks are ownership slices of a business, we should value stocks like we value businesses. A business is worth the discounted value of all future cash flow that it can generate. Joe Mansueto,

Think like a business owner.

If stocks are ownership slices of a business, we should value stocks like we value businesses. A business is worth the discounted value of all future cash flow that it can generate. Joe Mansueto,

If stocks are ownership slices of a business, we should value stocks like we value businesses. A business is worth the discounted value of all future cash flow that it can generate. Joe Mansueto, founder of Morningstar, explains it: An investor should think like a business owner, not a renter. Most business people don’t get up in the morning and ask whether they should sell their business that day. If they own a pizza shop, they don’t think about whether what they really should own is a shoe store instead. They show patience and persistence and try to understand their underlying business better so they can earn the greatest return for the longest period of time. Warren Buffett subscribes to the similar sentiment. “If you own your stocks as an investment—just like you’d own an apartment, house or a farm—look at them as a business. If you’re going to try to buy and sell them based on news or something your

They show patience and persistence and try to understand their underlying business better so they can earn the greatest return for the longest period of time. Warren Buffett subscribes to the similar sentiment. “If you own your stocks as an investment—just like you’d own an apartment, house or a farm—look at them as a business. If you’re going to try to buy and sell them based on news or something your neighbor tells you, you’re not going to do well. Find a good bunch of businesses and hold them,” he says. Stay within your circle of competence. An investor needs the ability to correctly evaluate selected businesses. You only have to be able to evaluate companies within your circle of competence. Do not be afraid to admit, “I don’t know” and/or that something is “too hard.” As Charlie Munger famously said: You’ll do better if you have

Read More – Share investment terms singaporeans generally considered wrong

Stay within your circle of competence. An investor needs the ability to correctly evaluate selected businesses. You only have to be able to evaluate companies within your circle of competence. Do not be afraid to admit, “I don’t know” and/or that something is “too hard.” As Charlie Munger famously said: You’ll do better if you have a passion for something in which you have the aptitude. If Warren had gone into ballet, no one would have heard of him. Having said that, remember that investing is a multidisciplinary exercise. Read widely. Look for wisdom in unconventional places, and always keep an eye out for opportunities. It was Benjamin Franklin who noted that “an investment in knowledge pays the best interest.” Keep an eye on value and price. According to Howard Marks, the “awareness of the relationship between price and value —whether for a single security or an entire market — is an essential component of dealing successfully with risk.” Focus on the value of the securities just as much as the price. If we know the price but do not know the value, we know nothing. One becomes a better athlete by practicing, not watching the scoreboard. Valuation matters. Paying too high a price for a stock can lead to disappointing returns, even if the underlying company subsequently performs wonder­fully. Look for situations where a company has to meet or exceed a low set of expectations priced in by the market. Don’t ignore Margin of Safety. There are two ways to make money in the stock market: Own businesses that will grow in value over time. Buy things below intrinsic value, and wait for the market to come around to recognize that value. Try to do both. The future is inherently uncertain, and one should always demand a margin of safety. The more uncertain a situation, the greater the margin of safety should be. To understand Margin of Safety, read How to buy stocks and cut your risk. According to Seth Klarman, a margin of safety is necessary because valuation is an imprecise art, the future is unpredictable, and investors are human and do make mistakes.

Look at Moats.

Businesses that have strong and sustainable competitive advantages—a wide an economic moat—will increase in value at a greater rate than those that do not. Wide-moat firms are also best suited for survival, possessing the high ground that will flood last, if at all, when a downturn hits. Focus on these firms. As Mohnish Pabrai explains: Moats are critically important. They are usually critical to the ability to generate future cash flows. Even if one invests with a time horizon of 2-3 years, the moat is quite important. The value of the business after 2-3 years is a function of the future cash it is expected to generate beyond that point. All I’m trying to do is buy a business for half (or less) than its intrinsic value 2-3 years out. In some cases intrinsic value grows dramatically over time. That’s ideal. But even if intrinsic value does not change much over time, if you buy at 50 cents and sell at 90 cents in 2-3 years, the return on invested capital is very acceptable. If you’re buying and holding forever, you need very durable moats. In that case you must have increasing intrinsic values over time. Regardless of your initial intrinsic value discount, eventually your return will mirror the annualized increase/decrease in intrinsic value. Look at reputation of the management. This works both ways. Look at the reputation of the management of the business you are investing in. And, also keep a tab on yourself. Warren Buffett advises investors to maintain a sterling reputation for honesty by “never doing something you wouldn’t want to see reported on the front page of your local newspaper.” Buffett, when chairman of Salomon Inc, famously told a Congressional panel that he had a simple message for employees in the wake of a scandal in 1991: “Lose money for the firm and I will be understanding. Lose a shred of reputation for the firm and I will be ruthless.” Patience is a virtue in investing. Activity for activity’s sake is harmful since frictional trading costs can greatly harm returns. Aim to minimize commissions, brokerage, taxes, and fees. As Paul Samuelson says, “investing should be like watching paint dry or watching grass grow. If you want excitement…go to Las Vegas.”

Read More – Stock Investment Tactics to Consider In Singapore Stock Market for Assured Output

Buy things below intrinsic value, and wait for the market to come around to recognize that value. Try to do both. The future is inherently uncertain, and one should always demand a margin of safety. The more uncertain a situation, the greater the margin of safety should be. To understand Margin of Safety, read How to buy stocks and cut your risk. According to Seth Klarman, a margin of safety is necessary because valuation is an imprecise art, the future is unpredictable, and investors are human and do make mistakes. Look at Moats. Businesses that have strong and sustainable competitive advantages—a wide an economic moat—will increase in value at a greater rate than those that do not. Wide-moat firms are also best suited for survival, possessing the high ground that will flood last, if at all, when a downturn hits. Focus on these firms. As Mohnish Pabrai explains: Moats are critically important. They are usually critical to the ability to generate future cash flows. Even if one invests with a time horizon of 2-3 years, the moat is quite important. The value of the business after 2-3 years is a function of the future cash it is expected to generate beyond that point. All I’m trying to do is buy a business for half (or less) than its intrinsic value 2-3 years out. In some cases intrinsic value grows dramatically over time. That’s ideal. But even if intrinsic value does not change much over time, if you buy at 50 cents and sell at 90 cents in 2-3 years, the return on invested capital is very acceptable. If you’re buying and holding forever, you need very durable moats. In that case you must have increasing intrinsic values over time. Regardless of your initial intrinsic value discount, eventually your return will mirror the annualized increase/decrease in intrinsic value. Look at reputation of the management. This works both ways. Look at the reputation of the management of the business you are investing in. And, also keep a tab on yourself. Warren Buffett advises investors to maintain a sterling reputation for honesty by “never doing something you wouldn’t want to see reported on the front page of your local newspaper.” Buffett, when chairman of Salomon Inc, famously told a Congressional panel that he had a simple message for employees in the wake of a scandal in 1991: “Lose money for the firm and I will be understanding. Lose a shred of reputation for the firm and I will be ruthless.” Patience is a virtue in investing. Activity for activity’s sake is harmful since frictional trading costs can greatly harm returns. Aim to minimize commissions, brokerage, taxes, and fees. As Paul Samuelson says, “investing should be like watching paint dry or watching grass grow. If you want excitement…go to Las Vegas.”

Don’t go overboard with diversification.

There is a dosage effect regarding portfolio diver­sity. Diversity is important to have, but too much can also dilute best ideas and excess returns. It can actu­ally be safer to have fewer baskets if it affords a much-closer watching of the eggs. Buffett believes that wide diversification is only required when investors do not understand what they are doing. “Know what you own, and know why you own it.” is how Peter Lynch puts it. The greater the payoff odds (lower price/fair value ratio), the greater the weight a position should be in a portfolio, all else equal. Likewise, the greater the confidence in one’s projections, the greater the position size should be, all else equal.

Always consider opportunity costs.

We should not be afraid to sell a good opportunity to take advantage of a great opportunity. We can generate value by selling dollar bills trading for $0.90 to buy other dollar bills trading for $0.60.

Keep an eye on value and price. According to Howard Marks, the “awareness of the relationship between price and value —whether for a single security or an entire market — is an essential component of dealing successfully with risk.” Focus on the value of the securities just as much as the price. If we know the price but do not know the value, we know nothing. One becomes a better athlete by practicing, not watching the scoreboard.

Valuation matters.

Paying too high a price for a stock can lead to disappointing returns, even if the underlying company subsequently performs wonder­fully. Look for situations where a company has to meet or exceed a low set of expectations priced in by the market. Don’t ignore Margin of Safety. There are two ways to make money in the stock market: Own businesses that will grow in value over time. Buy things below intrinsic value, and wait for the market to come around to recognize that value. Try to do both. The future is inherently uncertain, and one should always demand a margin of safety. The more uncertain a situation, the greater the margin of safety should be. To understand Margin of Safety, read How to buy stocks and cut your risk.

Read More – How to Manage your Stock Investment?

According to Howard Marks, the “awareness of the relationship between price and value —whether for a single security or an entire market — is an essential component of dealing successfully with risk.” Focus on the value of the securities just as much as the price. If we know the price but do not know the value, we know nothing. One becomes a better athlete by practicing, not watching the scoreboard. Valuation matters. Paying too high a price for a stock can lead to disappointing returns, even if the underlying company subsequently performs wonder­fully. Look for situations where a company has to meet or exceed a low set of expectations priced in by the market.

Don’t ignore Margin of Safety.

There are two ways to make money in the stock market: Own businesses that will grow in value over time. Buy things below intrinsic value, and wait for the market to come around to recognize that value. Try to do both. The future is inherently uncertain, and one should always demand a margin of safety. The more uncertain a situation, the greater the margin of safety should be. To understand Margin of Safety, read How to buy stocks and cut your risk. According to Seth Klarman, a margin of safety is necessary because valuation is an imprecise art, the future is unpredictable, and investors are human and do make mistakes. Look at Moats. Businesses that have strong and sustainable competitive advantages—a wide an economic moat—will increase in value at a greater rate than those that do not. Wide-moat firms are also best suited for survival, possessing the high ground that will flood last, if at all, when a downturn hits. Focus on these firms. As Mohnish Pabrai explains: Moats are critically important. They are usually critical to the ability to generate future cash flows. Even if one invests with a time horizon of 2-3 years, the moat is quite important. The value of the business after 2-3 years is a function of the future cash it is expected to generate beyond that point. All I’m trying to do is buy a business for half (or less) than its intrinsic value 2-3 years out. In some

There are two ways to make money in the stock market:

Own businesses that will grow in value over time. Buy things below intrinsic value, and wait for the market to come around to recognize that value. Try to do both. The future is inherently uncertain, and one should always demand a margin of safety. The more uncertain a situation, the greater the margin of safety should be. To understand Margin of Safety, read How to buy stocks and cut your risk. According to Seth Klarman, a margin of safety is necessary because valuation is an imprecise art, the future is unpredictable, and investors are human and do make mistakes. Look at Moats. Businesses that have strong and sustainable competitive advantages—a wide an economic moat—will increase in value at a greater rate than those that do not. Wide-moat firms are also best suited for survival, possessing the high ground that will flood last, if at all, when a downturn hits. Focus on these firms. As Mohnish Pabrai explains: Moats are critically important. They are usually critical to the ability to generate future cash flows. Even if one invests with a time horizon of 2-3 years, the moat is quite important. The value of the business after 2-3 years is a function of the future cash it is expected to generate beyond that point. All I’m trying to do is buy a business for half (or less) than its intrinsic value 2-3 years out. In some

Look at Moats.

Businesses that have strong and sustainable competitive advantages—a wide an economic moat—will increase in value at a greater rate than those that do not. Wide-moat firms are also best suited for survival, possessing the high ground that will flood last, if at all, when a downturn hits. Focus on these firms. As Mohnish Pabrai explains: Moats are critically important. They are usually critical to the ability to generate future cash flows. Even if one invests with a time horizon of 2-3 years, the moat is quite important. The value of the business after 2-3 years is a function of the future cash it is expected to generate beyond that point. All I’m trying to do is buy a business for half (or less) than its intrinsic value 2-3 years out. In some

Businesses that have strong and sustainable competitive advantages—a wide an economic moat—will increase in value at a greater rate than those that do not. Wide-moat firms are also best suited for survival, possessing the high ground that will flood last, if at all, when a downturn hits. Focus on these firms. As Mohnish Pabrai explains: Moats are critically important. They are usually critical to the ability to generate future cash flows. Even if one invests with a time horizon of 2-3 years, the moat is quite important. The value of the business after 2-3 years is a function of the future cash it is expected to generate beyond that point. All I’m trying to do is buy a business for half (or less) than its intrinsic value 2-3 years out. In some

Businesses that have strong and sustainable competitive advantages—a wide an economic moat—will increase in value at a greater rate than those that do not. Wide-moat firms are also best suited for survival, possessing the high ground that will flood last, if at all, when a downturn hits. Focus on these firms. As Mohnish Pabrai explains: Moats are critically important. They are usually critical to the ability to generate future cash flows. Even if one invests with a time horizon of 2-3 years, the moat is quite important. The value of the business after 2-3 years is a function of the future cash it is expected to generate beyond that point. All I’m trying to do is buy a business for half (or less) than its intrinsic value 2-3 years out. In some

Businesses that have strong and sustainable competitive advantages—a wide an economic moat—will increase in value at a greater rate than those that do not. Wide-moat firms are also best suited for survival, possessing the high ground that will flood last, if at all, when a downturn hits. Focus on these firms. As Mohnish Pabrai explains: Moats are critically important. They are usually critical to the ability to generate future cash flows. Even if one invests with a time horizon of 2-3 years, the moat is quite important. The value of the business after 2-3 years is a function of the future cash it is expected to generate beyond that point. All I’m trying to do is buy a business for half (or less) than its intrinsic value 2-3 years out. In some cases intrinsic value grows dramatically over time. That’s ideal. But even if intrinsic value does not change much over time, if you buy at 50 cents and sell at 90 cents in 2-3 years, the return on invested capital is very acceptable. If you’re buying and holding forever, you need very durable moats. In that case you must have increasing intrinsic values over time. Regardless of your initial intrinsic value discount, eventually your return will mirror the annualized increase/decrease in intrinsic value. Look at

Look at the reputation of the management.

This works both ways. Look at the reputation of the management of the business you are investing in. And, also keep a tab on yourself. Warren Buffett advises investors to maintain a sterling reputation for honesty by “never doing something you wouldn’t want to see reported on the front page of your local newspaper.” Buffett, when chairman of Salomon Inc, famously told a Congressional panel that he had a simple message for employees in the wake of a scandal in 1991: “Lose money for the firm and I will be understanding. Lose a shred of reputation for the firm and I will be ruthless.”

Patience is a virtue in investing.

Activity for activity’s sake is harmful since frictional trading costs can greatly harm returns. Aim to minimize commissions, brokerage, taxes, and fees. As Paul Samuelson says, “investing should be like watching paint dry or watching grass grow. If you want excitement…go to Las Vegas.” Don’t go overboard with diversification. There is a dosage effect regarding portfolio diver­sity. Diversity is important to have, but too much can also dilute best ideas and excess returns. It can actu­ally be safer to have fewer baskets if it affords a much-closer watching of the eggs. Buffett believes that wide diversification is only required when investors do not understand what they are doing. “Know what you own, and know why you own it.” is how Peter Lynch puts it. The greater the payoff odds (lower price/fair value ratio), the greater the weight a position should be in a portfolio, all else equal. Likewise, the greater the confidence in one’s projections, the greater the position size should be, all else equal. Always consider opportunity costs. We should not be afraid to sell a good opportunity to take advantage of a great opportunity. We can generate value by selling dollar bills trading for $0.90 to buy other dollar bills trading for $0.60.

Don’t be afraid to go against the crowd. As Benjamin Graham wrote, in the short term, the market is a voting machine. Popularity rules the day. In the long term,

As Benjamin Graham wrote, in the short term, the market is a voting machine. Popularity rules the day. In the long term, the market is a weighing machine, gravitating toward a company’s true intrinsic value. Buy on the cannons (when stocks are unpopular), sell on the trumpets (when euphoria reigns). John Templeton wisely says, “If you want to have a better performance than the crowd, you must do things differently from the crowd.” Which means, invest at the point of maximum pessimism.

As Benjamin Graham wrote, in the short term, the market is a voting machine. Popularity rules the day. In the long term,

In the short term, the market is a voting machine. Popularity rules the day. In the long term, the market is a weighing machine, gravitating toward a company’s true intrinsic value. Buy on the cannons (when stocks are unpopular), sell on the trumpets (when euphoria reigns). John Templeton wisely says, “If you want to have a better performance than the crowd, you must do things differently from the crowd.” Which means, invest at the point of maximum pessimism.

 
Leave a comment

Posted by on October 16, 2017 in Uncategorized

 

Good Time to Sell or Buy SingPost

  • Boost from 701Search stake sale
  • Sound approach to rationalization
  • FV estimate updated to S$2.93

FY17 PATMI Boosted by One-time Divestment Gain

Singapore-momentum-stocks-SingPost
SPH reported that FY17 PATMI increased 32.0% YoY to S$350m mostly due to a gain of S$150m from a partial divestment of the group’s stake in the regional online classifieds business, and a fair value gain on investment properties of S$57m, which were partially offset by impairment charges of S$96m on the group’s magazine business and printing presses.

Excluding these one-time charges, however, FY17 recurring earnings declined 20% YoY and FY17 operating revenues also declined 8% lower as the core media business continued to suffer the disruption of digital media. The property segment, however, delivered steady results as revenues increased 1% YoY from higher rental income from the group’s retail assets.

We deem this set of results to be mostly within our expectations. A final dividend of 9 S-cents per share has been proposed, bringing total dividends in FY17 to 15 S-cents.

Catch more – Good Time to Buy Keppel Corp

Sound Approach to Rationalizing Media Business

While there is no denying the impact of digital disruption on the group’s core media earnings – which continue to decline over the latest quarter – our view is that the management team’s approach in rationalizing the business is mostly realistic and sound. The group will complete a 10% staff reduction by this calendar year, incurring retrenchment costs of S$13m, and will also invest for new growth in terms of digital, data analytics, radio broadcasts, video and content marketing capabilities. This will also help the group better meet the changing needs of their market.

Since we have upgraded the stock to a buy rating three weeks ago, we note that the price has rebounded but, as we update our valuation model for the latest results and assumptions, our fair value estimate declines to S$2.93 versus S$3.25 previously. We, therefore, downgrade our rating to HOLD on valuation grounds.

More Update: Stocks To Watch and hot stocks picks with Stock trading tips or Share Market Tips

 
Leave a comment

Posted by on October 13, 2017 in Stocks

 

Tags: , , , , , , , , , , , , ,

[SINGAPORE STOCK] Singapore Press Holdings Update

SPH reported that FY17 PATMI increased 32.0% YoY to S$350.1m mostly due to a gain of S$149.7m from a partial divestment of the group’s stake in the regional online classifieds business, and a fair value gain on investment properties of S$57.4m, which were partially offset by impairment charges of S$96m on the group’s magazine business and printing presses.

Singapore-momentum-stocks-SingPost

Excluding these one-time charges, however, FY17 recurring earnings declined 20.2% YoY and FY17 operating revenues also declined 8.2% lower as the core media business continued to suffer the disruption from digital media.

The property segment, however, delivered steady results as revenues increased 1.2% YoY from higher rental income from the group’s retail assets.

We deem this set of results to be mostly within our expectations. We put our rating and fair value estimate of S$3.25 under review.

More Update:Share trading tips, SGX Stock Picks, Share Market signals for Singapore stock Market

Venture Corp Share Investment Singapore www.mmfsolutions.sg

 
Leave a comment

Posted by on October 12, 2017 in Uncategorized

 

[Singapore Stock] QT VASCULAR LTD Movements

Currently trading around a penny a share Singapore Stock QT Vascular (QTVLF) is one of the most undervalued biotech/medical stocks I have ever seen! With FDA and EU approval for it’ s coronary products, a new partnership with the World&rsquo s leading medical device company, US sales booming, backed by the government of Singapore with large foreign institutional and insider ownership, received a US Congressional award, revenues projected to skyrocket (already in the millions), debt being slashed about to become cash flow positive with expansion into Europe and Asia ramping up! Crazy undervalued now, the share price is only going to rise!

QT Vascular (QTVLF) is already selling their FDA and European Union approved coronary balloon catheter’ s and other coronary angioplasty products to over 150 Hospitals in the US alone! With US sales BOOMING and projected to skyrocket, that is just the beginning! Read this entire write up and you will be stunned how EXTREMELY UNDERVALUED QT Vascular (QTVLF) is!

All due diligence posted here is verifiable and comes straight from the CEO, the company’ s filings, audited financials, website and official press releases!….

QTVLF ALSO now has full FDA clearance and has begun clinical trials on a NEW revolutionary drug-coated coronary balloon catheter that is less invasive and does not involve placing a permanent implant!

QT Vascular (QTVLF) is a global company engaged in the development and commercialization of innovative devices for the minimally invasive treatment of vascular disease without the use of permanent implants (stents).

Currently moving Near – 0.010 with Moderate Range. Stay Alert with Singapore market Movements

QT Vascular (QTVLF) HIGHLIGHTS

,,,,,,,

1-QTVLF CEO says debt at the end of 2016 was slashed by approximately US$7.8 million from US$19.2 million in 2015 to US$11.4 million. With US sales growing and the new agreement for distribution with the world&rsquo s leading medical device company global giant Medtronics CEO says debt will continue to be taken out through 2017! (Strong Buy Signal!)

2-QTVLF is backed by the Singaporean government who is fast becoming a world leader in promoting life sciences, investing heavily in firms and in the sort of infrastructure that will support the industry through it’ s state-financed biomedical sciences investment fund (BMSIF)

3-QTVLF also backed by other major established and reputable shareholders include Three Arch Partners, a healthcare fund which has internally incubated more than a dozen start-up healthcare companies AND Luminor Pacific Fund 1 is a private equity healthcare-focused fund based in Singapore approved under the Singapore government&rsquo s global investor programme.

4-QTVLF following the AWESOME new 2017 agreement with Medtronic that went into effect March 1st 2017 the company then received an offer for up to $20 MILLION CAPITAL COMMITMENT on favorable terms from US-based New York private investment group GEM GLOBAL. GEM is a USD 3.4 billion investment group having completed 372 transactions in 70 countries. (Strong Buy Signal!)
….

5-QTVLF CEO says they are currently selling their coronary balloon catheter’ s and other coronary angioplasty products to over 150 Hospitals in the United States alone! (Strong Buy Signal!)

6-QTVLF has filed over 40 patents filed worldwide on it’ s coronary balloon catheter’ s and other coronary angioplasty products

7-QTVLF Awards and Recognition: company received a Certificate of Special Congressional Recognition from U.S. Congressman Jerry McNerney

8-QTVLF Awards and Recognition the company subsidiary, TriReme US, was recognized by the City of Pleasanton where it is based for its ongoing contributions to the strength of the economy locally and positive impacts to the quality of life globally

9-QTVLF is the first ever Singapore based biotech medical company to receive approval US Food and Drug Administration (&ldquo FDA&rdquo ) for an interventional medical device developed in Singapore
….

10-QTVLF is heading towards being CASH FLOW POSITIVE, reduced loss from US$53.1 million in FY2015 to US$12.0 million in FY2016, That is phenomenal! With the new distribution agreement with the world&rsquo s leading medical device company, Medtronic complete debt elimination and massive revenue increases will continue! (Strong Buy Signal!)

11-QTVLF CEO says that US sales in 2106 of it’ s coronary products increased a WHOPPING 49% equalling an increased per sales representative efficiency of 114% (Strong Buy Signal!)

12-QTVLF PRODUCTS are in DEMAND, CEO says they working hard to increase production in support of the new distribution agreement.the world&rsquo s leading medical device company, Medtronic. (Strong Buy Signal!)

13-QTVLF CEO says that in 2016 the US remained the companies largest market, accounting for 86.9% of total revenue. Sales to Europe improved during the year. Europe accounted for 5.8% of total revenue with US$620,000 in sales, compared with US$426,000 a year ago. With the new 2017 agreement with the world&rsquo s leading medical device company, Medtronic global and European sales are forecast to substantially increase!

14-QTVLF has obtained the approval from the US Food and Drug Administration (&ldquo FDA&rdquo ) to sell an improved version of it’ s coronary angioplasty product named Chocolate® PTCA known as Chocolate XD® (Strong Buy Signal!)

15-QTVLF ALSO received full approval from the US Food and Drug Administration (&ldquo FDA&rdquo ) to begin the pivotal study of the drug-coated version of it’ s coronary angioplasty product Chocolate® PTA known as Chocolate Touch® . This is only the 4th such device to ever receive such approval by the FDA (Strong Buy Signal!)

Read More – Things Most People Don’t Know About Qt Vascular Target Price

16-QTVLF on July 31, 2017, company announced it has started enrollment in its US Food and Drug Administration (&ldquo FDA&rdquo ) pivotal clinical study. The study will evaluate the Company’ s drug-coated balloon (” DCB” ), the Chocolate Touch® , for use in superficial femoral and popliteal arteries with the intention of obtaining a US regulatory approval. The co-principal investigators of the study are Dr. Mehdi Shishehbor of the University Hospitals of Cleveland and Professor Thomas Zeller of the Heart Center in Bad Krozingen, Germany.

17-QTVLF has generated awesome positive clinical data It’ s coronary angioplasty product Chocolate PTA achieved a 0% failure rate during a human trial study on 22 patients in Germany and New Zealand for one year, and subsequent follow-ups showed no complications. Data from the first 350 patients of a separate human trial study of the Chocolate PTA in the United States showed high rates of treatment success and limb preservation. (Strong Buy Signal!)CEO says ” We are delighted with the angiographic results of Chocolate Heart&trade showing maintenance of patency at two years,” stated Eitan Konstantino, PhD, CEO of QT Vascular. ” Those patients are doing well without a stent in their heart and this is exactly what we are here for.” (Strong Buy Signal!)

CEO also said ” in keeping with our commitment to proving the clinical value of our technology, we announced the 12 month outcomes of the Chocolate Heart® First-in-Human Study, the final results of the US registry of Chocolate® PTA known as Chocolate BAR, and the final results of the Chocolate Touch® First-in-Human trial known as ENDURE. The results of all of these studies added significantly to the body of evidence supporting the unique benefits of the Chocolate® platform” (Strong Buy Signal!)

Read More – Advanced Guide to Qt Vascular Target Price

18-QTVLF In Europe has ALSO obtained CE mark clearance for Chocolate Heart® , the coronary drug-coated balloon (Strong Buy Signal!)

19-QTVLF new cutting-edge proprietary technologies: CEO on the NEW revolutionary drug-coated coronary products ” The area of peripheral arterial disease remains very much under-treated. While stents are used to treat some of these patients, there is a growing preference for therapies such as drug-coated balloons that do not involve placing a permanent implant. Sales of drug-coated balloons are estimated to have surpassed US$300 million in 2016 in the US market and the global market will surpass US$1 billion in sales by 20202. QT Vascular is well positioned to benefit from the increased adoption of drug-coated balloons. Chocolate Touch® has received full FDA clearance to begin the pivotal trial. Upon approval, this would make Chocolate Touch® only the 4th such device to be approved in the US.

The final results of Chocolate Touch® &rsquo s first-in-human trials are similar to the best-in-class devices. The Company&rsquo s recently announced a distribution agreement with Medtronic, along with the recent launch of the Group&rsquo s latest generation coronary device, Chocolate XD® , bode well for supporting our growth in FY2017.” (Strong Buy Signal!)

Read More –  Signs You Work With Qt Vascular Target Price

20-QTVLF while conducting most of it’ s business in the US it is strategically located in Singapore, a hub of Asia and have access to the markets in the PRC and Japan through distribution agreements. The business-friendly environment in Singapore will allow the use Singapore as the Asian hub for the companies Asian focused marketing activities, revenues in Asia which are forecast to grow significantly with the companies new outreach into mainland ChinaThe companies top markets include the USA and growing medical device markets, especially in Europe, China, Japan and other parts of Asia. CEO says ” Our products are focused on the treatment of cardiovascular diseases, which are the number one cause of death globally, and half of all such cases are estimated to occur in Asia”

21-QTVLF expansion into mainland China, a distribution agreement with Weihai Weigao Medical Devices, Ltd. for the distribution of our peripheral products, the GliderXtreme PTA, GliderfleX PTA and Chocolate PTA coronary products in the People&rsquo s Republic of China.Weihai Weigao Medical Devices is a leading supplier of medical devices in China.Weihai Weigao has an extensive sales network comprising 25 sales offices, 38 customer liaison centers, and 170 municipal representative offices. As at the date of this report, Weihai Weigao has a total customer base of 5,159 (including 3,090 hospitals, 414 blood stations, 611 other medical units and 1,044 distributors). (Strong Buy Signal!)

22-QTVLF expansion into mainland China, QTVLF ALSO recently announced that it has signed an agreement with the Administrative Committee of Shijiazhuang High-Tech Industry Development Zone and China VAST Industrial Urban Development Company Limited to explore opportunities for cooperation in areas including, inter alia, project development, biotechnology sharing, talent exchange and fundraising. SJZ High-Tech Zone and China VAST shall provide the land for research and development within SJZ High-Tech Zone, and assist QT Vascular in obtaining capital and other resources. SJZ High-Tech Zone shall assist to present QT Vascular’ s biotechnology and its products to companies in SJZ High-Tech Zone, to explore opportunities such as joint research and development programs and the distribution of QT Vascular’ s products in China.

23-QTVLF already has a distribution agreement with Japan-based Century Medical Inc for the distribution of QTVLF products in Japan. Century Medical is one of the largest independent medical device distributors in Japan. With over 40 years experience marketing medical devices in Japan.

Read More- Greatest Moments in Qt Vascular Target Price History

24-QTVLF Top Management Executive Vice President Ms. Pizarro spent 10 years at Boston Scientific, Neurovascular Division, where she led neurovascular minimally invasive device research (intracranial implantable devices) and development projects from concept to commercialization. Prior to joining TriReme, Ms. Pizarro was the Director of Research and Development at AngioScore Inc., where she led the development of cardiovascular and peripheral devices QT Vascular (QTVLF) Company Description

QT Vascular Ltd., together with its subsidiaries, designs, assembles and distributes therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The company offers coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma by providing balloon inflation and Glider PTCA for the treatment of various complex lesions.
It also provides Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for the treatment of blocked arteries Chocolate Touch, a drug-coated balloon catheter GliderfleX PTA for treating distal peripheral vessels and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature.

The company sells its products through its direct sales team. It has operations in the United States, Singapore, Japan, Europe, China, Australia, and Hong Kong. QT Vascular Ltd. was incorporated in 2013 and is based in Singapore.

Summary

Now is the time to buy shares of QT Vascular Ltd. (QTVLF), trading near historic lows and under the radar this award-winning biotech medical company is about to become cash flow positive. With millions in revenues and debt being slashed, new funding now being offered on favorable terms, like the $20 million from Global Emerging Markets, the US-based investment group as institutions discover the value that QT Vascular Ltd. (QTVLF) presents!

Partnering up with the the world’s leading medical device company global giant Medtronic, US sales setting NEW RECORDS and BOOMING and with the company making significant headway into the Asian markets especially China you can see how EXTREMELY UNDERVALUED this biotech is trading around a penny!

When you factor in the support it receives from the country of Singapore through it’ s state-financed biomedical sciences investment fund and the huge percentage of shares that insiders and foreign institutions own it easily stands out to me as one of America’ s MOST UNDERVALUED stocks!

I do not know of any biotech stock or otherwise, that is trading around a penny that has been recognized and received an award from the US Congress and from a US City and that also has multiple products ALREADY APPROVED by both the FDA and the EU. With it’ s products already being commercialized and new cutting edge FDA trials approved and happening the share price is only going to rise from this point.

 
Leave a comment

Posted by on October 11, 2017 in Stocks

 

Tags: , , , , , , , ,

Singapore Stock City Developments Limited Update

  • Possible offer for M&C
  • Cash offer of 552.5 pence per share
  • Likely accretive if successful

Possible Cash Offer of 552.5 Pence Per M&C Share

Singapore Stock City Developments Limited Update

CDL announced that they have reached an agreement with the independent directors of Millennium & Copthorne Hotels PLC (M&C) on the price at which these directors will recommend a possible cash offer by CDL for all the outstanding M&C ordinary shares that CDL does not already own. As at 9 Oct 2017, CDL indirectly owns 65.2% of the shares of M&C.

The proposed cash consideration comprises a cash amount of 545 pence per M&C share and a special dividend of 7.5 pence per share which will be payable upon the offer becoming unconditional. This represents a 22.0% premium to the VWAP of 452.7 pence per share over the period of one month before 6 Oct 2017, and also a 21.4% premium to the closing share price of 455.0 pence on 6 Oct 2017.

No Certainty That a Formal Offer Will be Made

We highlight that there is no certainty a formal offer will be made, and discussions on the other terms and conditions of the proposed offer are still ongoing. If successful, we see this as a positive development for CDL which will almost certainly be accretive. Given green shoots in the global economy, the outlook for hospitality assets is broadly turning positive.

In addition, CDL already indirectly owns a substantial stake in M&C, and intimately understands its expansive hotel portfolio and business model as an owner and operator. Against this backdrop, it makes sense for CDL to fully consolidate its hotel subsidiary – if the right price can be agreed upon.

In our view, while the potential cash offer price is fairly attractive for CDL, it also offers M&C shareholders a valuable opportunity for liquidity at a sizeable 21.4% premium to the last closing price on 6 Oct.

Pending a formal offer, our fair value estimate of S$12.90 for CDL remains unchanged. Maintain BUY.

Momentum Singapore Stocks To Watch

  • DELONG
  • APAC REALTY
  • ROWSLEY
  • ASTI
  • GSS ENERGY

So Earn more With our Stock Recommendations

More Update: Stocks To Watch and hot stocks picks with Stock trading tips or Share Market Tips

 
Leave a comment

Posted by on October 11, 2017 in Stocks

 

Tags: , , , , , , , , , , , , ,

Singapore Stock Rowsley Limited update

Rowsley Limited Set To Become One Of Raffles Medical Group Ltd’s Competitors Soon
.
Singapore Stock Rowsley Limited (SGX: A50), a real estate company with businesses in design and engineering, real estate development and hospitality, made public that it plans to set foot into the healthcare sector.

This will be done by purchasing a 100% stake of Thomson Medical Pte Ltd and a 70.36% stake of TMC Life Sciences Berhad (0101.KL), a company listed in Malaysia. These assets are currently owned by the billionaire, Peter Lim. As at 16 March 2017, he owned close to 46% of Rowsley.

The proposed acquisition, which is valued at up to S$1.9 billion, is going to be an all-share deal and will be financed through the issuance of new shares of Rowsley at S$0.075 per share. This translates to a creation of 25.3 billion new shares. A Sales and Purchase Agreement is expected to be completed within two months.

Rowsley added that the “proposed acquisition will also bring TMCLS’s proposed Thomson Iskandar project in Iskandar, Johor, together with Rowsley’s investment in Vantage Bay Healthcare City”. Thomson Iskandar is an integrated development that comprises of a general hospital, medical suites, and a retail mall.

Mr. Ng Ser Miang, Rowsley’s Chairman said:

This proposed acquisition is an opportunity for us to acquire controlling stakes in two established healthcare assets in Singapore and Malaysia and be part of an expanding business. Healthcare is a big and growing market due to aging demographics, longer lifespan, major trends to increase birth rates, and growing affluence. This deal will diversify Rowsley’s portfolio as well as strengthen our current businesses. It will also significantly increase Rowsley’s market capitalization, market profile, and generate investor interest.

Upon completion of the deal, the firm plans to issue two bonus warrants for every one existing share owned by a shareholder and an additional warrant (known as a piggyback warrant) for every bonus warrant that is exercised. Each bonus warrant will have an exercise price of S$0.09 per share while each piggyback warrant will have an exercise price of S$0.12 per share.

Singapore Stock Market watchers will remember that back in 2010, Mr. Lim privatized Thomson Medical Centre, which was a listed company here, for S$513 million. Seven years later, the medical practice is going to return to the market. Rowsley said that it “may also consider changing its name to incorporate the word “Thomson” after completion” of the deal.

Currently, Rowsley’s outstanding shares is 4.74 billion. With a current price of S$0.117, the market capitalization is S$554.4 million. As a comparison, the largest private medical group practice in Singapore, Raffles Medical Group Ltd. (SGX: BSL), has a market cap of S$2.28 billion.

 
Leave a comment

Posted by on October 10, 2017 in Stocks